Stock Incentive Plans

12 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Incentive Plans

NOTE 9 - STOCK INCENTIVE PLANS

Stock Options

The following table summarizes stock option activity for the year-ended December 31, 2018:

	Options Outstanding
	Shares			Weighted Average Exercise Price
Outstanding, December 31, 2017		745,707		$	8.84
Options granted		4,984,000			0.66
Options expired / forfeited		(116,650	)		54.29
Outstanding, December 31, 2018		5,613,057			0.83
Exercisable, December 31, 2018		1,636,664		$	0.93

The following table summarizes additional information on Adhera’s stock options outstanding at December 31, 2018:

		Options Outstanding						Options Exercisable
Range of  Exercise  Prices		Number Outstanding		Weighted- Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
	$0.31 - $0.98		4,965,000		8.66	$	0.64		1,467,500	$	0.73
	$1.00		7,000		2.88	$	1.00		7,000	$	1.00
	$1.50 - $1.80		493,207		8.68	$	1.79		134,314	$	1.78
	$2.60 - $8.20		135,200		3.52	$	2.77		15,200	$	4.48
	$10.70 - $22.00		12,650		0.75	$	10.92		12,650	$	10.92
	Totals		5,613,057		8.97	$	0.83		1,636,664	$	0.93

Weighted-Average Exercisable Remaining Contractual Life (Years) 8.03

In January 2018, the Company granted a total of 19,000 stock options to directors and officers for services. The options have an exercise price of $1.56 and a five-year term.

In May 2018, the Company granted a total of 380,000 stock options to departing directors and officers for services. The options have an exercise price of $0.98 and a five-year term.

In July 2018, we granted our Chief Executive Officer, 1,500,000 stock options; Uli Hacksell, Ph.D., the Chairman of our Board, 1,000,000 stock options; and Erik Emerson, our Chief Commercial Officer, 1,125,000 stock options at an exercise prices of $0.66 per share with a 10-year term.

In July 2018, we granted our SVP of Commercial Operations 250,000 stock options at an exercise price of $0.575 per share with a 10-year term.

In September 2018 we granted our Chief Financial Officer 450,000 stock options at an exercise price of $0.55 per share with a 10-year term.

During the three months ended December 31, 2018, we granted an aggregate of 260,000 stock options to employees at exercise prices ranging from $0.31 to $0.53 per share with a 10-year term. The options vest at a rate of one-third at the end of each annual anniversary over three years from the grant date.

As of December 31, 2018, we had $1,185,627 of total unrecognized compensation expense related to unvested stock options. Total expense related to stock options was $1,445,138 and $178,784 for the year ended December 31, 2018 and 2017, respectively.

As of December 31, 2018, the intrinsic value of options outstanding or exercisable was $0 as there were no options outstanding with an exercise price less than $0.28, the per share closing market price of our common stock at that date.